Non-Hodgkin Lymphoma: Recurrence
When non-Hodgkin lymphoma recurs, there are several treatment options your doctor may prescribe.
Recurrence: What to Know About Recurrence
- Access our condensed Treatment Guide here.
- The most common first treatment after relapse is another round of chemotherapy
- For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence
- Access our condensed Treatment Guide here.
- The most common first treatment after relapse is another round of chemotherapy
- For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
The Watch & Wait Approach to Recurrence
With some cancers, immediate treatment is essential. You don't want to let a cancer that started at an early stage -- especially an aggressive one -- progress to a late stage where it's more widespread and harder to stop. This is also the case with aggressive non-Hodgkin lymphomas, such as diffuse large B-cell lymphoma... Read More
- Your doctor may recommend a stem cell transplant if cancer has recurred
- Stem cell transplants involve a high-dose of chemotherapy, followed by an infusion of stem cells taken from your body before treatment
- Recovery can be harsh, so this treatment method is not recommended for all patients
Recurrence: Stem-Cell Transplant
- Your doctor may recommend a stem cell transplant if cancer has recurred
- Stem cell transplants involve a high-dose of chemotherapy, followed by an infusion of stem cells taken from your body before treatment
- Recovery can be harsh, so this treatment method is not recommended for all patients
- CAR T-cell therapy involves training a person’s own immune cells to target and attack cancer cells
- This exciting new therapy is providing a lot of hope in the non-Hodgkin lymphoma field, but it cannot be given to all patients
- It has shown success in treating relapsed diffuse large B-cell lymphoma
Recurrence: CAR T-Cell Therapy
- CAR T-cell therapy involves training a person’s own immune cells to target and attack cancer cells
- This exciting new therapy is providing a lot of hope in the non-Hodgkin lymphoma field, but it cannot be given to all patients
- It has shown success in treating relapsed diffuse large B-cell lymphoma
Weighing Your Options
The majority of patients who are diagnosed with diffuse large B-cell lymphoma, the most common type of lymphoma, will be cured with a standard approach. "Most of those patients will be approached with frontline, anthracycline-based chemotherapy, plus an immune therapy in the form of an antibody that targets a protein o... Read More
Recurrence: What Are Bispecific Antibodies?
Non-Hodgkin Lymphoma - Looking to the Future
Chemotherapy is still the main treatment for most people with non-Hodgkin lymphoma, but it's no longer the only treatment for this cancer. Today, doctors have new drugs at their disposal to treat lymphoma in entirely different ways, and other new therapies are working their way through clinical trials. CAR T-cell thera... Read More
Richter's Transformation: How Leukemia Can Turn into Non-Hodgkin Lymphoma
Chronic lymphocytic leukemia often changes into a type of non-Hodgkin lymphoma called diffuse large B-cell lymphoma. Rarely, it turns into a form of Hodgkin lymphoma. If your cancer does change, your doctor will need to put you on a more aggressive treatment to control it. Chronic lymphocytic leukemia (CLL) is a slow-g... Read More
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.